11 countries in South-East Asia are making progress against their AMR National Action Plans, new WHO report shows
06 January 2023
Supported by a range of key stakeholders (including the Fleming Fund), the World Health Organization (WHO) recently published the Third Progress Analysis of the Implementation of Antimicrobial Resistance National Action Plans (NAP-AMRs) in South-East Asia.
The analysis shows that progress against the NAP-AMR was made in all eleven WHO Member States in the region during the period from 2018 to 2021, with Bhutan, Indonesia and Thailand making the greatest advancements. This is despite the COVID-19 pandemic and its associated challenges.
Further reading: Fleming Fund
Author(s): Fleming Fund
Effective Surveillance
OUR UNDERWRITERS
Unrestricted financial support by:
 |
LifeArc |
 |
Antimicrobial Resistance Fighter Coalition |
 |
Bangalore Bioinnovation Centre |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
Ambassador Network
Join the AMR Insights Ambassador Network today!
Connect to over 550 AMR professionals and students in 60 countries!
